Jazz Pharmaceuticals is an international biopharmaceutical company, focused on identifying, developing, and commercializing products for neurology and psychiatry. The company's products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of homocystinuria, an inherited metabolic disease; and Antizol to treat ethylene glycol and methanol poisoning.